Clinical Trial Update: The Safety and Efficacy of Deferoxamine for Treating Unresectable Hepatocellular Carcinoma [Phase 1]

View source ↗

Summary

This clinical trial update reports a Phase 1 study evaluating the safety and efficacy of deferoxamine for unresectable hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Desferal (Deferoxamine Mesylate)

Snippet

Sponsor: Jinan Military General Hospital | Conditions: Hepatocellular Carcinoma Non-resectable | Phase 1 | Status: UNKNOWN